Annual Report

153830 Words616 Pages
Contact information Registered office and corporate headquarters AstraZeneca PLC 2 Kingdom Street London W2 6BD UK Tel: +44 (0)20 7604 8000 Fax: +44 (0)20 7604 8151 Investor relations Email: ir@astrazeneca.com UK: as above Sweden: Investor Relations AstraZeneca AB SE-151 85 Södertälje Sweden Tel: +46 (0)8 553 260 00 Fax: +46 (0)8 553 290 00 US: Investor Relations AstraZeneca Pharmaceuticals LP 1800 Concord Pike PO Box 15437 Wilmington DE 19850-5437 US Tel: +1 (302) 886 3000 Fax: +1 (302) 886 2972 Registrar Equiniti Limited Aspect House Spencer Road Lancing West Sussex BN99 6DA UK Tel (freephone in the UK): 0800 389 1580 Tel (outside the UK): +44 (0)121 415 7033 US Depositary JPMorgan Chase & Co PO Box 64504 St Paul MN 55164-0504 US Tel (toll free in the US): 888 697 8018 Tel (outside the US): +1 (651) 453 2128 Email: jpmorgan.adr@wellsfargo.com Swedish Central Securities Depository Euroclear Sweden AB PO Box 191 SE-101 23 Stockholm Sweden Tel: +46 (0)8 402 9000 health This Annual Report is also available on our website, astrazeneca.com/annualreport2011 AstraZeneca Annual Report and Form 20-F Information 2011 AstraZeneca Annual Report and Form 20-F Information 2011 Important information for readers of this Annual Report Cautionary statement regarding forward-looking statements The purpose of this Annual Report is to provide information to the members of the Company. The Company and its Directors, employees, agents and advisors do not accept or assume responsibility to any other person to whom this Annual Report is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed. In order, among other things, to utilise the ‘safe harbour’ provisions of the US Private Securities Litigation Reform Act of 1995 and the UK Companies Act 2006, we

More about Annual Report

Open Document